VITAE PHARMACEUTICALS INC's ticker is VTAE and the CUSIP is 92847N103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $11,337,000 | +84.1% | 541,906 | -5.0% | 0.00% | +100.0% |
| Q2 2016 | $6,157,000 | +142.4% | 570,657 | +49.0% | 0.00% | – |
| Q1 2016 | $2,540,000 | -54.5% | 383,040 | +24.2% | 0.00% | -100.0% |
| Q4 2015 | $5,584,000 | +68.2% | 308,482 | +2.3% | 0.00% | 0.0% |
| Q3 2015 | $3,319,000 | +3.7% | 301,421 | +35.6% | 0.00% | 0.0% |
| Q2 2015 | $3,201,000 | +2.3% | 222,294 | -16.8% | 0.00% | – |
| Q1 2015 | $3,128,000 | – | 267,147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERAL MOTORS INVESTMENT MANAGEMENT CORP | 26,023 | $287,000 | 11.12% |
| BVF INC/IL | 2,375,933 | $26,159,000 | 5.28% |
| AWM Investment Company, Inc. | 795,624 | $8,760,000 | 1.70% |
| Ghost Tree Capital, LLC | 250,000 | $2,753,000 | 1.24% |
| HAMILTON LANE ADVISORS LLC | 170,935 | $1,882,000 | 0.93% |
| DAFNA Capital Management LLC | 70,885 | $780,000 | 0.77% |
| RA Capital Management | 321,161 | $3,536,000 | 0.51% |
| HARBOURVEST PARTNERS LLC | 85,217 | $938,000 | 0.41% |
| Atika Capital Management LLC | 45,000 | $495,000 | 0.24% |
| Perceptive Advisors | 400,000 | $4,404,000 | 0.18% |